STOCKWATCH
·
Specialty Chemicals
Quarterly ResultApr 30, 2026, 04:53 PM

CLX Q3 Net Sales $1.67B, EPS $1.54; Glad Venture Ends; GOJO Financing

AI Summary

Clorox reported Q3 2026 net sales of $1,670 million, a slight increase from $1,668 million in Q3 2025, with diluted EPS rising to $1.54 from $1.50. For the nine months, net sales decreased to $4,772 million from $5,116 million, and net earnings attributable to Clorox fell to $424 million from $478 million. The company completed the purchase of P&G's 20% interest in the Glad bags and wraps business for $476 million. Additionally, Clorox secured new credit agreements totaling $2,250 million to finance a portion of the previously announced GOJO Industries, Inc. acquisition.

Key Highlights

  • Glad Venture Agreement with P&G ended; CLX purchased P&G's 20% interest for $476M.
  • Secured $2,250M in new credit facilities for the GOJO Industries, Inc. acquisition.
  • Q3 2026 net sales were $1,670M, a slight increase from $1,668M in Q3 2025.
  • Q3 2026 diluted EPS was $1.54, up from $1.50 in the prior year quarter.
  • Nine-month net sales decreased to $4,772M from $5,116M year-over-year.
  • Nine-month net earnings attributable to Clorox fell to $424M from $478M.
  • Cash and cash equivalents rose to $1,187M from $167M at June 30, 2025.
  • Notes and loans payable increased to $1,591M from $4M at June 30, 2025.
CLX
Specialty Chemicals
CLOROX CO /DE/

Price Impact